Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schenk

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Zentralblatt Fur Chirurgie|January 1, 1996
[Percutaneous transhepatic stent implantation versus hepaticojejunostomy in palliative therapy of distal malignant bile duct stenosis]K Trautwein, H Waldner, C Rock, et al.
Seminars in Thrombosis and Hemostasis|May 18, 1999
Training of patients for self-management of oral anticoagulant therapy: standards, patient suitability, and clinical aspectsS Mörsdorf, W Erdlenbruch, U Taborski, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2003
On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopeniaJoachim F Schenk, Gerhard Pindur, Bernhard Stephan, et al.
Thrombosis Research|November 30, 1999
Platelet-induced thrombin generation time II (PITT II). A modified global coagulation test to monitor prophylactic anticoagulation with vitamin K antagonists?P Radziwon, B Boczkowska-Radziwon, J F Schenk, et al.
Molecular Biology and Evolution|May 17, 2013
Patterns of Epistasis between beneficial mutations in an antibiotic resistance geneMartijn F Schenk, Ivan G Szendro, Merijn L M Salverda, et al.
Melanoma Research|September 14, 2000
Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cellsA J Schrader, M Probst-Kepper, J Grosse, et al.
Thrombosis Research|January 11, 2001
Platelet activation and its role in thrombin generation in platelet-induced thrombin generation timeP Radziwon, B Boczkowska-Radziwon, J F Schenk, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Heparin-induced thrombocytopenia: a critical risk/benefit analysis of patients in intensive care treated with R-hirudinJ F Schenk, G Berg, S Mörsdorf, et al.
Evolutionary Applications|April 11, 2015
Role of pleiotropy during adaptation of TEM-1 β-lactamase to two novel antibioticsMartijn F Schenk, Sariette Witte, Merijn L M Salverda, et al.
Cellular Immunology|December 16, 2011
Both exogenous commensal and endogenous self antigens stimulate T cell proliferation under lymphopenic conditionsJeong-su Do, Gilles Foucras, Nobuhiko Kamada, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Zentralblatt Fur Chirurgie|January 1, 1996
[Percutaneous transhepatic stent implantation versus hepaticojejunostomy in palliative therapy of distal malignant bile duct stenosis]K Trautwein, H Waldner, C Rock, et al.
Seminars in Thrombosis and Hemostasis|May 18, 1999
Training of patients for self-management of oral anticoagulant therapy: standards, patient suitability, and clinical aspectsS Mörsdorf, W Erdlenbruch, U Taborski, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2003
On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopeniaJoachim F Schenk, Gerhard Pindur, Bernhard Stephan, et al.
Thrombosis Research|November 30, 1999
Platelet-induced thrombin generation time II (PITT II). A modified global coagulation test to monitor prophylactic anticoagulation with vitamin K antagonists?P Radziwon, B Boczkowska-Radziwon, J F Schenk, et al.
Molecular Biology and Evolution|May 17, 2013
Patterns of Epistasis between beneficial mutations in an antibiotic resistance geneMartijn F Schenk, Ivan G Szendro, Merijn L M Salverda, et al.
Melanoma Research|September 14, 2000
Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cellsA J Schrader, M Probst-Kepper, J Grosse, et al.
Thrombosis Research|January 11, 2001
Platelet activation and its role in thrombin generation in platelet-induced thrombin generation timeP Radziwon, B Boczkowska-Radziwon, J F Schenk, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Heparin-induced thrombocytopenia: a critical risk/benefit analysis of patients in intensive care treated with R-hirudinJ F Schenk, G Berg, S Mörsdorf, et al.
Evolutionary Applications|April 11, 2015
Role of pleiotropy during adaptation of TEM-1 β-lactamase to two novel antibioticsMartijn F Schenk, Sariette Witte, Merijn L M Salverda, et al.
Cellular Immunology|December 16, 2011
Both exogenous commensal and endogenous self antigens stimulate T cell proliferation under lymphopenic conditionsJeong-su Do, Gilles Foucras, Nobuhiko Kamada, et al.
Pageof 8